Milligan Graeme
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
Eur J Pharm Sci. 2004 Mar;21(4):397-405. doi: 10.1016/j.ejps.2003.11.010.
Bioluminescence (BRET)- and fluorescence resonance energy transfer (FRET) techniques have become integral approaches in studies of protein-protein interactions in living cells. They rely on non-radiative transfer of energy between donor and acceptor species that can be appended to the proteins of interest. These techniques display exquisite dependence on distance and orientation between the energy transfer partners. This means they are well suited to measure both small conformational changes in response to ligand binding between partner proteins that remain within a complex or more extensive translocations of proteins between cellular compartments that occur in response to cellular challenge. Introduction of both energy donor and acceptor into a single polypeptide can also allow the detection of ligand-induced conformational switches in monomeric proteins in the millisecond time scale. Many of these approaches are amenable to high throughput screening and the drug discovery process. G protein-coupled receptors (GPCRs) represent a key drug target class. Specific applications of resonance energy transfer techniques to the identification of ligands for this class of protein are highlighted to illustrate general principles.
生物发光共振能量转移(BRET)和荧光共振能量转移(FRET)技术已成为研究活细胞中蛋白质-蛋白质相互作用的不可或缺的方法。它们依赖于供体和受体物种之间的非辐射能量转移,这些物种可以附加到感兴趣的蛋白质上。这些技术对能量转移伙伴之间的距离和方向表现出极高的依赖性。这意味着它们非常适合测量因配体结合而在复合物中保持的伙伴蛋白质之间的小构象变化,或响应细胞挑战而发生的细胞区室之间蛋白质的更广泛易位。将能量供体和受体引入单个多肽中还可以在毫秒时间尺度上检测单体蛋白质中配体诱导的构象转换。这些方法中的许多都适用于高通量筛选和药物发现过程。G蛋白偶联受体(GPCR)是一类关键的药物靶点。本文重点介绍了共振能量转移技术在鉴定这类蛋白质配体方面的具体应用,以阐明一般原理。